Name | Address | City |
---|---|---|
Northeast Treatment Behavior | 2205 Bridge Street | Philadelphia |
Hamilton Treatment Services | 3444 Quakerbridge Rd building 1a | Hamilton Square |
Solid Rock Recovery, LLC | 208 White Horse Pike Suite 3 | Barrington |
Hospital of the University of Pennsylvania – Cedar Avenue | 501 South 54th St. | Philadelphia |
The Consortium, Inc. – University City Recovery Center | 451 S University Ave | Philadelphia |
JEVS Achievement Through Counseling and Treatment ACT I | 5820 Old York Road | Philadelphia |
Aldie Foundation, Inc. | 11 Welden Dr | Doylestown |
Camden Treatment Associates | 508 Atlantic Ave | Camden |
Serenity Health Elkton | 953 W Pulaski Highway | Elkton |
ARS of New Castle | 263 Quigley Blvd Suite 1A | New Castle |
JEVS Achievement Through Counseling and Treatment ACT II | 1745 N 4th Street | Philadelphia |
Thomas Jefferson University Narcotic Addiction Rehab Program | NE Corner of South 21st Street and | Philadelphia |
John F Kennedy Community Mental Health | 907 North Broad Street | Philadelphia |
Amha Inc | 928 Market Street | Philadelphia |
Methadone Clinic Philadelphia | 1233 Locust St | Philadelphia |
SOAR Corp | 655 Louis Drive | Warminster Heights |
Soar Corporation Levittown | 7500 Bristol Pike | Levittown |
Vineland Treatment Services | 1051 W. Sherman Ave Bldg 4 | Vineland |
Trenton Healthcare Clinic | 801 New York Ave | Trenton |
Soar Corporation Philadelphia | 9150 Marshall St #2217 | Philadelphia |
No results found!
Lansdowne, Pennsylvania is a borough in Delaware County, with a population of 10,647. Named after the Marquess of Lansdowne, the borough is located six miles from the Philadelphia City Center. Although Lansdowne is convenient to larger cities, there are enough methadone clinics in Pennsylvania for there to be a Lansdowne methadone clinic closer at hand for residents of this borough who need opioid addiction treatment. Ever since the 1960s, methadone has been given to patients to prevent the massive drop in neurotransmitters that would otherwise be caused when a person chemically-addicted to opioids quits taking drugs. By keeping neurotransmitter levels even, opioid withdrawals and drug cravings are prevented, not only sparing people in recovery a great deal of suffering, but likely allowing them to feel better than they have in a long time. Furthermore, methadone also blocks opioid receptors in the brain so that patients will not be able to get intoxicated by drinking alcohol or taking opioids. This prevents relapse, which would not only derail recovery, but would also cause a dangerous chemical interaction with methadone.